Latest News

inh-logo

Inhalosome-C receives Enterprise Award

Saturday, 16 November 2013

The Inhalosome-C project received an Enterprise Award with our partners at the University of Strathclyde: University of Strathclyde Glasgow Enterprise Awards for November 2013 as the Best Academic Commercialisation Project.


Agreement signed with MacKenzies Partnership

Wednesday, 4 September 2013

An agreement was signed with MacKenzies Partnership Ltd in Harrogate to assist in finding, reviewing, and assessing any potential investors for the project.


University of Stratchclyde Project

Tuesday, 17 July 2012

The University of Stratchclyde have asked Biovaxpharma Ltd  to assist them in developing the commercialisation project for Inhalosome-Cisplatin development for lung cancer via nebulized method of treatment. View more at www.Inhalosome.com


  • inh-logo

    Inhalosome-C receives Enterprise Award

    Saturday, 16 November 2013

    The Inhalosome-C project received an Enterprise Award with our partners at the University of Strathclyde: University of Strathclyde Glasgow Enterprise Awards for November 2013 as the Best Academic Commercialisation Project.

  • Agreement signed with MacKenzies Partnership

    Wednesday, 4 September 2013

    An agreement was signed with MacKenzies Partnership Ltd in Harrogate to assist in finding, reviewing, and assessing any potential investors for the project.

  • University of Stratchclyde Project

    Tuesday, 17 July 2012

    The University of Stratchclyde have asked Biovaxpharma Ltd  to assist them in developing the commercialisation project for Inhalosome-Cisplatin development for lung cancer via nebulized method of treatment. View more at www.Inhalosome.com

About us

We offer customised development services for companies translating scientific ideas into clinical development plans.

Our company is built on the principles of advising and delivering quality products and providing a reliable cohesive service.

Our diversified product range continues to grow by following trends, improving our standard products, and listening to the customer. Our unique service has established our place in the pharma industry. This allows us to make a distinctive and substantial impact for our clients.

Services

Services include:
  • Strategic analysis of the way forward for your formulation or device
  • Target Product Profile Planning; Formulation advice
  • Clinical Development Plans & Project Management.
  • Manufacturing assistance; Assay qualification and validation; Stability
  • Testing advice
  • Regulatory Consulting and meetings with the EU or FDA advisory groups
  • Ethics, Health Economics & Pediatric research advice from early stages of
  • Pharma to the Licence and Investment stages
Get in touch

Staff Members

  • Dr. Tony Lockett

    Tony is a medical doctor specialising in the development of pharmaceuticals and devices. He has worked for over 20 Years in this sector, and has developed and registered many pharmaceuticals.

    Recently he has written development plans; marketing applications; gap analysis for using foreign data in both the USA and EU IND applications; NDA for novel drug delivery systems; MAA for new chemical entities on the USA and EU. He also advises on clinical trials in rare or tropical diseases as he is trained in microbiology.

  • Dr. Allan Watkinson

    Allan trained as protein biochemist with an honours degree in Biochemistry and a PhD in Physiological Biochemistry. He has an excellent research and development background gained from over 10 years in academic research followed by 20 years’ experience in research and development in the biotechnology and cosmetic industries.

    During this time he has been an author on multiple peer reviewed scientific papers and inventor for several patent applications. Currently specialising in the development of vaccines taking the initial concept up to licensure. This includes providing strategic and tactical leadership with experience in leading multi-functional technical teams to deliver development program goals.

    Experienced in vaccine formulation, process and analytical development, cGMP manufacturing, stability studies and pre-clinical animal studies. In particular, has proven expertise in vaccine formulation, including selection/incorporation of adjuvants and vaccine stabilisation, and advanced analytical techniques. Combined with this, he has experience in liaising with government agencies, commercial organisations and academia.

  • Jacqueline Watkinson

    Jacqueline has a background in Zoology and Animal Physiology. During 12 years spent working in this field, she has gained experience in performing a wide range of animal studies; both for basic research and in support of developmental pharmaceuticals.

    Following from this then moved into the Hospital sector working in cytopathology, database management and in patient management of clinical trials. She also has 5 years’ experience in the pharmaceutical industry in Quality Control; working with cGLP/GMP, initially in microbiology and finally in managing biopharmaceutical stability trials.

  • Elizabeth Lockett

    Elizabeth has run a successful business for the last 7 years in assisting companies in early stage phase 1/2 pharmaceuticals , in regards to development and regulatory requirements. Assisting in the documentation and research that support taking companies through the steps required for their compounds and products, to facilitate them in achieving meetings with the MHRA or FDA.

    She has a degree is an MBA in Information Systems Management from Bournemouth University together with background in health in the public sector as an oncology nurse. She has worked as a Consultant to the health sector advising on their information systems and the logistics of information and strategy concerns within a National Health Trust.

    She has also worked for a consultancy practice doing general consulting , change management, and troubleshooting to find out what happens in departments, information and work wise, as opposed to what is thought to be how they work.

Dr. Tony Lockett

Tony is a medical doctor specialising in the development of pharmaceuticals and devices. He has worked for over 20 Years in this sector, and has developed and registered many pharmaceuticals.

Recently he has written development plans; marketing applications; gap analysis for using foreign data in both the USA and EU IND applications; NDA for novel drug delivery systems; MAA for new chemical entities on the USA and EU. He also advises on clinical trials in rare or tropical diseases as he is trained in microbiology.


Dr. Allan Watkinson

Allan trained as protein biochemist with an honours degree in Biochemistry and a PhD in Physiological Biochemistry. He has an excellent research and development background gained from over 10 years in academic research followed by 20 years’ experience in research and development in the biotechnology and cosmetic industries.

During this time he has been an author on multiple peer reviewed scientific papers and inventor for several patent applications. Currently specialising in the development of vaccines taking the initial concept up to licensure. This includes providing strategic and tactical leadership with experience in leading multi-functional technical teams to deliver development program goals.

Experienced in vaccine formulation, process and analytical development, cGMP manufacturing, stability studies and pre-clinical animal studies. In particular, has proven expertise in vaccine formulation, including selection/incorporation of adjuvants and vaccine stabilisation, and advanced analytical techniques. Combined with this, he has experience in liaising with government agencies, commercial organisations and academia.


Jacqueline Watkinson

Jacqueline has a background in Zoology and Animal Physiology. During 12 years spent working in this field, she has gained experience in performing a wide range of animal studies; both for basic research and in support of developmental pharmaceuticals.

Following from this then moved into the Hospital sector working in cytopathology, database management and in patient management of clinical trials. She also has 5 years’ experience in the pharmaceutical industry in Quality Control; working with cGLP/GMP, initially in microbiology and finally in managing biopharmaceutical stability trials.


Elizabeth Lockett

Elizabeth has run a successful business for the last 7 years in assisting companies in early stage phase 1/2 pharmaceuticals , in regards to development and regulatory requirements. Assisting in the documentation and research that support taking companies through the steps required for their compounds and products, to facilitate them in achieving meetings with the MHRA or FDA.

She has a degree is an MBA in Information Systems Management from Bournemouth University together with background in health in the public sector as an oncology nurse. She has worked as a Consultant to the health sector advising on their information systems and the logistics of information and strategy concerns within a National Health Trust.

She has also worked for a consultancy practice doing general consulting , change management, and troubleshooting to find out what happens in departments, information and work wise, as opposed to what is thought to be how they work.

Contact

Phone: +44 (0)113 8582050
Email: info@biovaxpharma.us

Address:
BioVaxPharma Ltd.
15 Queens Square
Leeds
West Yorkshire
LS2 8AJ

Get in Touch

Your Name

Your Message